Toyocamycin

Overview
Catalog #	bs-82573c-5-mg
Product Name	Toyocamycin
Specifications
Storage Buffer	Supplied as solution in Ethanol at a concentration of 25 ug/200 ul.
Storage Condition	-20°C
Target
Product Information	An adenosine analog which inhibits ribozyme self cleavage in mammalian cells, EC50 = 0.4 M (for expression of a luciferase reporter)1. A potent inhibitor of ER stress-induced XBP1 mRNA splicing2. It suppresses thapsigargin-, tunicamycin- and 2-deoxyglucose-induced XBP1 mRNA splicing in HeLa cells without affecting ATF6 and PERK activation. Although unable to inhibit IRE1 phosphorylation, it prevented IRE1-induced XBP1 mRNA cleavage in vitro. It inhibits not only ER stress-induced but also constitutive activation of XBP1 expression in multiple myeloma cell lines as well as in primary patient samples2. Displays synergistic effects with bortezomib. Inhibits unfolded protein response and induces apoptosis in pancreatic cancer cells3.
Description	CAS Number: 606-58-6 Chemical Name: 4-Amino-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile Molecular weight: 291.26 Formula: C12H13N5O4 Solubility: DMSO (25 mg/ml) Moderately soluble in water Physical Properties: White or off-white solid Purity: 97% by TLC, NMR (Conforms)